BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 9920167)

  • 21. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
    Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
    Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory investigations for bleeding disorders.
    Hayward CP; Moffat KA; Liu Y
    Semin Thromb Hemost; 2012 Oct; 38(7):742-52. PubMed ID: 23011792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of isotretinoin on prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT).
    Kaptanoglu AF; Uncu M; Ozyurt S; Hincal E
    J Dermatolog Treat; 2013 Aug; 24(4):272-4. PubMed ID: 22188511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of Routine Preoperative Tests for Coagulation Before Elective Cranial Surgery. Results of an Institutional Audit and a Nationwide Survey of Neurosurgical Centers in Pakistan.
    Akhunzada NZ; Tariq MB; Khan SA; Sattar S; Tariq W; Shamim MS; Dogar SA
    World Neurosurg; 2018 Aug; 116():e252-e257. PubMed ID: 29730103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prothrombin time and thromboplastin time. On-site measurement of the prothrombin time and activated partial thromboplastin time of surgical patients with laser photometry].
    Tschaikowsky K; Balint R; Pscheidl E; Bremer F
    Anaesthesist; 1998 Apr; 47(4):295-302. PubMed ID: 9615846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of normal versus abnormal activated partial thromboplastin time and prothrombin time after cardiopulmonary bypass.
    Nuttall GA; Oliver WC; Beynen FM; Santrach PJ; Strickland RA; Murray MJ
    J Cardiothorac Vasc Anesth; 1995 Aug; 9(4):355-61. PubMed ID: 7579102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.
    Burns ER; Goldberg SN; Wenz B
    Am J Clin Pathol; 1993 Aug; 100(2):94-8. PubMed ID: 8356955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in prothrombin and activated partial thromboplastin time during replacement therapy with human recombinant growth hormone in growth hormone deficient adults.
    Miljic D; Miljic P; Doknic M; Pekic S; Djurovic M; Colovic M; Popovic V
    Hormones (Athens); 2006; 5(3):187-91. PubMed ID: 16950752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agreement of point-of-care prothrombin and activated partial thromboplastin time in dogs with a reference laboratory.
    Yang W; Hosgood G; Luobikis K; Paul A
    Aust Vet J; 2018 Oct; 96(10):379-384. PubMed ID: 30255579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time].
    Kagawa K; Fukutake K
    Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of an abnormal coagulation profile in children qualified for adenoidectomy/tonsilectomy].
    Kitszel A; Poznańska M; Krawczuk-Rybak M
    Otolaryngol Pol; 2007; 61(2):158-61. PubMed ID: 17668802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents.
    Ten Boekel E; Böck M; Vrielink GJ; Liem R; Hendriks H; de Kieviet W
    Thromb Res; 2007; 121(3):361-7. PubMed ID: 17568658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of Routine Coagulation Tests in Healthy Children Undergoing Elective Minor Surgery: a 12-Year Retrospective Study.
    Song J; Jung HW; Lee EH; Chang HK; Yoon HS
    Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma.
    Yuan S; Ferrell C; Chandler WL
    Thromb Res; 2007; 120(1):29-37. PubMed ID: 16887171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation factors V, VIII, and X, prothrombin time and activated partial thromboplastin time test results in thawed plasma stored at 1-6 ºC for 5 days.
    Naghadeh HT; Maghsudloo M; Tabatabaei MR
    Blood Transfus; 2011 Jan; 9(1):95-8. PubMed ID: 21235855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of the effect of reagent modification on routine laboratory coagulation tests.
    Gentry PA; Feldman BF; O'Neill SL
    Equine Vet J; 1992 Jan; 24(1):30-2. PubMed ID: 1555536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Exploration of hemostasis in current practice].
    Aiach M; Gaussem P
    Ann Pharm Fr; 1996; 54(1):21-4. PubMed ID: 8702189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing.
    Tripodi A; Chantarangkul V; Mannucci PM
    Br J Haematol; 2009 Oct; 147(1):77-82. PubMed ID: 19659548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venom Concentrations and Clotting Factor Levels in a Prospective Cohort of Russell's Viper Bites with Coagulopathy.
    Isbister GK; Maduwage K; Scorgie FE; Shahmy S; Mohamed F; Abeysinghe C; Karunathilake H; O'Leary MA; Gnanathasan CA; Lincz LF
    PLoS Negl Trop Dis; 2015; 9(8):e0003968. PubMed ID: 26296235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.